TREACE MEDICAL CONCEPTS INC (TMCI)

Treace Medical Concepts is Now Oversold (TMCI)

Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour

Partnership to help pickleball players of all levels with bunions and related midfoot deformities to “get back on their feet” and out on the court...

Treace to Present at Bank of America Health Care Conference

Wednesday, May 15, 2024, at 2:20 pm Pacific Time

Treace Announces First Annual National Bunion Day

Focus on Foot Health Issue Affecting Millions of People Includes Outreach and Education Efforts to Build Awareness, Reduce Stigma and Correct Misconceptions About This Common Bone Deformity

Treace Announces First Annual National Bunion Day

Focus on Foot Health Issue Affecting Millions of People Includes Outreach and Education Efforts to Build Awareness, Reduce Stigma and Correct...

7 Stable Stocks for 50% Returns by Early 2025

These 7 stable stocks also offer 50% returns according to analysts according to analysts tasked with following their respective industries.

Treace to Report First Quarter 2024 Financial Results

Company to Host Conference Call on Tuesday, May 7, 2024 at 4:30 pm ET

Treace to Report First Quarter 2024 Financial Results

Company to Host Conference Call on Tuesday, May 7, 2024 at 4:30 pm ET...

Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone

Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone

Treace Further Expands Focus on Bunion Deformity Education by Sponsoring First-Ever National Bunion Day in the U.S. on April 16, 2024 Launches...

Treace Medical Concepts Enters Oversold Territory (TMCI)

Notable Wednesday Option Activity: TGTX, TMCI, NVTS

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance

PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology...

Treace to Report Fourth Quarter and Full-Year 2023 Financial Results

Company to Host Conference Call on Tuesday, February 27, 2024 at 4:30 pm ET

Treace to Report Fourth Quarter and Full-Year 2023 Financial Results

Company to Host Conference Call on Tuesday, February 27, 2024 at 4:30 pm ET...

Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

PONTE VEDRA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology...

Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference

Company Previews New SpeedPlate™ Configurations, Announces Full Commercial Release of its Micro-Lapiplasty™ System and Limited Clinical Release of its Mini-Adductoplasty™ System and RedPoint™ Patient-Specific Instrumentation

Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference

Company Previews New SpeedPlate™ Configurations, Announces Full Commercial Release of its Micro-Lapiplasty™ System and Limited Clinical Release of its...

Commit To Purchase Treace Medical Concepts At $10, Earn 16.9% Annualized Using Options

Noteworthy Monday Option Activity: JOBY, TMCI, LOVE

Treace Medical forecasts upbeat Q4, 2023 revenue outlook (NASDAQ:TMCI)

Treace Medical Concepts exceeds Q4 revenue expectations, with a 2023 outlook also surpassing analyst forecasts.

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue

Company to Present at J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 3:45 pm Pacific Time

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue

Company to Present at J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 3:45 pm Pacific Time...

Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference

Tuesday, January 9, 2024, at 3:45 pm Pacific Time

Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference

Tuesday, January 9, 2024, at 3:45 pm Pacific Time...

Treace Medical Concepts Becomes Oversold (TMCI)

Treace Medical Concepts Reports Third Quarter 2023 Financial Results

Treace Medical Concepts Reports Third Quarter 2023 Financial Results

PONTE VEDRA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction® Procedure, today reported financial results for the third quarter ended September 30, 2023.